Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System

摘要: Subcutaneous allergen immunotherapy (SCIT) is an effective treatment for allergic rhinitis, asthma and venom hypersensitivity has the potential of producing serious life-threatening anaphylaxis. Adverse reactions are generally classified into 2 categories: local reactions, which can manifest as redness, pruritus, swelling at injection site, systemic (SRs). SRs range in severity from mild rhinitis to fatal cardiopulmonary arrest. Early administration epinephrine, choice treat anaphylaxis, may prevent progression SR a more problem. Although there little debate about using epinephrine SCIT SR, lack consensus when it should be first used. A uniform classification system grading will helpful assessing accurately administered. The primary purpose this article discuss proposed SRs.